NS
Narasimhan Sridhar Nagaarjun
About Narasimhan Sridhar Nagaarjun
Data last updated:
Narasimhan Sridhar Nagaarjun is an Additional Director at Difgen Pharmaceuticals Private Limited (since 2025). The company operates in Research & Development. Difgen Pharmaceuticals Private Limited reported revenue of ₹76.63 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Difgen Pharmaceuticals Private Limited U72100TG2022PTC162383 | Additional Director | 13 Feb 2025 | 2022 | ₹76.63 Cr (FY 2025) | Active |
Board colleagues of Narasimhan Sridhar Nagaarjun
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amol Ashok Walke | 00664315 | Difgen Pharmaceuticals Private Limited | Director |
| Krishna Chandrasekaran | 10243796 | Difgen Pharmaceuticals Private Limited | Director |
| Punit Chunilal Thakrar | 00351619 | Difgen Pharmaceuticals Private Limited | Director |
| Ramandeep Singh Jaj | 09789813 | Difgen Pharmaceuticals Private Limited | Director |
| Santhanakrishnan Srinivasan | 09789679 | Difgen Pharmaceuticals Private Limited | Director |
| Srinivasan Vedantham | 09534573 | Difgen Pharmaceuticals Private Limited | Director |
| Valiveti Brahmaji | 00079255 | Difgen Pharmaceuticals Private Limited | Additional Director |
| Vijay Kumar Vasireddy | 03262782 | Difgen Pharmaceuticals Private Limited | Director |
| Yatin Kirtanlal Desai | 00030719 | Difgen Pharmaceuticals Private Limited | Director |
| Zubin Keki Gandhi | 00664632 | Difgen Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narasimhan Sridhar Nagaarjun
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narasimhan Sridhar Nagaarjun
Narasimhan Sridhar Nagaarjun currently holds 1 directorship: Difgen Pharmaceuticals Private Limited (Additional Director, since 13 Feb 2025, revenue ₹76.63 Cr (FY 2025)).
Narasimhan Sridhar Nagaarjun was first appointed on 13 Feb 2025 as Additional Director at Difgen Pharmaceuticals Private Limited.
The current boards of Narasimhan Sridhar Nagaarjun's companies include Amol Ashok Walke (Difgen Pharmaceuticals Private Limited), Krishna Chandrasekaran (Difgen Pharmaceuticals Private Limited), Punit Chunilal Thakrar (Difgen Pharmaceuticals Private Limited), Ramandeep Singh Jaj (Difgen Pharmaceuticals Private Limited), Santhanakrishnan Srinivasan (Difgen Pharmaceuticals Private Limited), Srinivasan Vedantham (Difgen Pharmaceuticals Private Limited), among others.